Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Cardiac toxicity 4 to 20 years after completing anthracycline therapy.

Steinherz LJ, Steinherz PG, Tan CT, Heller G, Murphy ML.

JAMA. 1991 Sep 25;266(12):1672-7.

PMID:
1886191
2.

Cardiac function in Wilms' tumor survivors.

Sorensen K, Levitt G, Sebag-Montefiore D, Bull C, Sullivan I.

J Clin Oncol. 1995 Jul;13(7):1546-56.

PMID:
7602343
3.

Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients.

Steinherz LJ, Steinherz PG, Tan C.

Med Pediatr Oncol. 1995 Jun;24(6):352-61.

PMID:
7715541
4.

Anthracycline-induced cardiac toxicity more likely in underweight childhood cancer survivors.

Andolina JR, Dilley K.

J Pediatr Hematol Oncol. 2010 Jul;32(5):411-5. doi: 10.1097/MPH.0b013e3181dccd37.

PMID:
20495481
5.

Anthracycline induced cardiac toxicity in pediatric Ewing sarcoma: a longitudinal study.

Brown TR, Vijarnsorn C, Potts J, Milner R, Sandor GG, Fryer C.

Pediatr Blood Cancer. 2013 May;60(5):842-8. doi: 10.1002/pbc.24404. Epub 2013 Feb 4.

PMID:
23382019
6.

Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study.

Sieswerda E, Kremer LC, Vidmar S, De Bruin ML, Smibert E, Sjöberg G, Cheung MM, Weintraub RG.

Pediatr Blood Cancer. 2010 Apr;54(4):579-84. doi: 10.1002/pbc.22371.

PMID:
20014238
7.

Echocardiographic evaluation of patients cured of childhood cancer: a single center study of 117 subjects who received anthracyclines.

Bossi G, Lanzarini L, Laudisa ML, Klersy C, Raisaro A, Aricò M.

Med Pediatr Oncol. 2001 Jun;36(6):593-600.

PMID:
11344489
8.

[High-resolution electrocardiography in monitoring myocardial damage after therapy with anthracyclines in children].

Mladosievicová B, Foltinová A, Bernadic M, Petrásová H, Hulín I.

Bratisl Lek Listy. 1996 May;97(5):289-97. Slovak.

PMID:
8705327
9.

Late cardiotoxicity after treatment for a malignant bone tumor.

Postma A, Bink-Boelkens MT, Beaufort-Krol GC, Kengen RA, Elzenga NJ, Schasfoort-van Leeuwen MJ, Schraffordt koops H, Kamps WA.

Med Pediatr Oncol. 1996 Apr;26(4):230-7.

PMID:
8600333
10.

Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults.

Larsen RL, Jakacki RI, Vetter VL, Meadows AT, Silber JH, Barber G.

Am J Cardiol. 1992 Jul 1;70(1):73-7.

PMID:
1615874
11.

[The role of dobutamine stress echocardiography in early diagnosis of cardiac toxicity in long-term survivors of asymptomatic children treated with anthracycline].

Yildirim A, Tunaoğlu FS, Pinarli FG, Ilhan M, Oğuz A, Karadeniz C, Olguntürk R, Oğuz D, Kula S.

Anadolu Kardiyol Derg. 2010 Apr;10(2):154-62. doi: 10.5152/akd.2010.042. Turkish.

12.

Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.

Leger K, Slone T, Lemler M, Leonard D, Cochran C, Bowman WP, Bashore L, Winick N.

Pediatr Blood Cancer. 2015 Jan;62(1):123-7. doi: 10.1002/pbc.25206. Epub 2014 Aug 30.

PMID:
25176022
13.

Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy.

Toro-Salazar OH, Gillan E, O'Loughlin MT, Burke GS, Ferranti J, Stainsby J, Liang B, Mazur W, Raman SV, Hor KN.

Circ Cardiovasc Imaging. 2013 Nov;6(6):873-80. doi: 10.1161/CIRCIMAGING.113.000798. Epub 2013 Oct 4.

14.

Regional cardiac wall motion abnormalities during and shortly after anthracyclines therapy.

Kapusta L, Groot-Loonen J, Thijssen JM, DeGraaf R, Daniëls O.

Med Pediatr Oncol. 2003 Nov;41(5):426-35.

PMID:
14515381
15.

Late cardiac damage of anthracycline therapy for acute lymphoblastic leukemia in childhood.

Prestor VV, Rakovec P, Kozelj M, Jereb B.

Pediatr Hematol Oncol. 2000 Oct-Nov;17(7):527-40.

PMID:
11033728
16.
17.

Echocardiographic Detection of Cardiac Dysfunction in Childhood Cancer Survivors: How Long Is Screening Required?

Ramjaun A, AlDuhaiby E, Ahmed S, Wang L, Yu E, Nathan PC, Hodgson DC.

Pediatr Blood Cancer. 2015 Dec;62(12):2197-203. doi: 10.1002/pbc.25651. Epub 2015 Jul 6. Erratum in: Pediatr Blood Cancer. 2017 Mar;64(3):.

18.

Is screening for abnormal ECG patterns justified in long-term follow-up of childhood cancer survivors treated with anthracyclines?

Pourier MS, Mavinkurve-Groothuis AM, Loonen J, Bökkerink JP, Roeleveld N, Beer G, Bellersen L, Kapusta L.

Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26243. Epub 2016 Sep 21.

PMID:
27654133
19.

Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study.

van Dalen EC, van der Pal HJ, Kok WE, Caron HN, Kremer LC.

Eur J Cancer. 2006 Dec;42(18):3191-8. Epub 2006 Sep 20.

PMID:
16987655
20.

B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children.

Aggarwal S, Pettersen MD, Bhambhani K, Gurczynski J, Thomas R, L'Ecuyer T.

Pediatr Blood Cancer. 2007 Nov;49(6):812-6.

Supplemental Content

Support Center